Carduso Capital

Carduso Capital operates as a venture capital firm, deploying capital into early-stage technology companies. The firm’s approach extends beyond mere funding, offering strategic expertise, proactive management guidance, and leveraging an international network to support its portfolio. It primarily targets enterprises within Life Sciences, Energy, and Sustainable Society sectors, especially those emerging from the University of Groningen (UG) and University Medical Center Groningen (UMCG).

Established in 2012, Carduso Capital was co-initiated by the University of Groningen, the University Medical Center Groningen, and experienced entrepreneur Frits Kok. The founding insight stemmed from recognizing the potential to commercialize groundbreaking academic research and address the early-stage funding requirements of promising technology ventures originating from these prominent knowledge institutions. Frits Kok's extensive background in high-tech SMEs and organizational development proved instrumental in the firm’s formation.

The firm's focus is on innovative technology companies seeking to translate scientific advancements into market-ready solutions. Carduso Capital's overarching mission is to foster value creation and facilitate the transformation of academic knowledge into profitable, sustainable technology businesses. Its long-term vision involves cultivating a robust ecosystem around the Groningen knowledge centers, propelling scientific innovation into commercial success.